| Single-cell immune landscape of human atherosclerotic plaques DM Fernandez, AH Rahman, NF Fernandez, A Chudnovskiy, ED Amir, ... Nature medicine 25, 1576-1588, 2019 | 772 | 2019 |
| A mechanistic framework for cardiometabolic and coronary artery diseases S Koplev, M Seldin, K Sukhavasi, R Ermel, S Pang, L Zeng, S Bankier, ... Nature Cardiovascular Research 1 (1), 85-100, 2022 | 72 | 2022 |
| SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels N Eberhardt, MG Noval, R Kaur, L Amadori, M Gildea, S Sajja, D Das, ... Nature cardiovascular research 2 (10), 899-916, 2023 | 68 | 2023 |
| FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease C Schneider, N Kon, L Amadori, Q Shen, FH Schwartz, B Tischler, ... Blood, The Journal of the American Society of Hematology 128 (5), 660-666, 2016 | 53 | 2016 |
| Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation YC Toner, AA Ghotbi, S Naidu, K Sakurai, MMT van Leent, S Jordan, ... Scientific reports 12 (1), 6185, 2022 | 27 | 2022 |
| Integrative prioritization of causal genes for coronary artery disease K Hao, R Ermel, K Sukhavasi, H Cheng, L Ma, L Li, L Amadori, S Koplev, ... Circulation: Genomic and Precision Medicine 15 (1), e003365, 2022 | 26 | 2022 |
| The IRG1–itaconate axis protects from cholesterol-induced inflammation and atherosclerosis Y Cyr, FK Bozal, JG Barcia Durán, AAC Newman, L Amadori, P Smyrnis, ... Proceedings of the National Academy of Sciences 121 (15), e2400675121, 2024 | 20 | 2024 |
| Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis L Amadori, C Calcagno, DM Fernandez, S Koplev, N Fernandez, R Kaur, ... Nature cardiovascular research 2 (6), 550-571, 2023 | 15 | 2023 |
| Systems Pharmacology Identifies an Arterial Wall Regulatory Gene Network Mediating Coronary Artery Disease Side Effects of Antiretroviral Therapy IP Itziar Frades , Ben Readhead , Letizia Amadori , Simon Koplev , Husain A ... Circulation: Genomic and Precision Medicine 12 (6), 2019 | 14 | 2019 |
| Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits BS Glicksberg, L Amadori, NK Akers, K Sukhavasi, O Franzén, L Li, ... BMC Medical Genomics 12 (Suppl 6), 108, 2019 | 8 | 2019 |
| Single-Cell Driven Drug Repositioning Approach Identifies a New Anti-Atherosclerotic Compound Targeting Myeloid Cells L Amadori, C Calcagno, DM Fernandez, S Koplev, NF Fernandez, R Kaur, ... Circulation 144 (Suppl_1), A13468-A13468, 2021 | 2 | 2021 |
| Immune profiling of atherosclerotic plaques identifies innate and adaptive dysregulations associated with ischemic cerebrovascular events DM Fernandez, AH Rahman, N Fernandez, A Chudnovskiy, ED Amir, ... bioRxiv, 721688, 2019 | 2 | 2019 |
| Zeb2 Regulates Senescence And Cytotoxic Phenotype In Atherosclerotic Plaque CD8 T Cells N Eberhardt, R Kaur, D Das, L Amadori, S Sajja, J Bresciani, M Gildea, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (Suppl_1), A1030-A1030, 2024 | 1 | 2024 |
| Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors JG Barcia Durán, D Das, M Gildea, L Amadori, M Gourvest, R Kaur, ... Nature Cardiovascular Research 3 (12), 1482-1502, 2024 | | 2024 |
| The immune checkpoint landscape in human atherosclerosis: influence of lipid lowering and type 2 diabetes JG Barcia Duran, D Das, M Gildea, L Amadori, M Gourvest, R Kaur, ... Circulation 150 (Suppl_1), A4132752-A4132752, 2024 | | 2024 |
| Effects Of Immune-checkpoint Inhibitors On Atherosclerosis In Halted Progression Model BT Cilhoroz, D Das, L Amadori, N Eberhardt, P Smyrnis, M Gourvest, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (Suppl_1), A107-A107, 2024 | | 2024 |
| IRG1-Itaconate Axis Protects From Cholesterol-Induced Inflammation And Atherosclerosis FK Bozal, Y Cyr, JG Barcia Duran, AAC Newman, L Amadori, P Smyrnis, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (Suppl_1), A124-A124, 2024 | | 2024 |
| Cytotoxic CD4+ T Cells: Unraveling The Residual Risk In Lipid Lowering For Type 2 Diabetes Patients D Das, N Eberhardt, L Amadori, M Gildea, R Kaur, swathy sajja, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (Suppl_1), A1028-A1028, 2024 | | 2024 |
| FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease (vol 128, pg 660, 2016) C Schneider, N Kon, L Amadori BLOOD 142 (24), 2125-2125, 2023 | | 2023 |
| Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis L Amadori, C Calcagno, DM Fernandez, S Koplev, N Fernandez, R Kaur, ... Nature Cardiovascular Research 2 (8), 793-793, 2023 | | 2023 |
David Dominguez-SolaIcahn School of Medicine at Mount SinaiAdresse e-mail validée de mssm.edu
